REIT - Healthcare Facilities
Compare Stocks
4 / 10Stock Comparison
HR vs OHI vs DOC vs SBRA
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Healthcare Facilities
REIT - Healthcare Facilities
HR vs OHI vs DOC vs SBRA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Healthcare Facilities |
| Market Cap | $6.98B | $13.74B | $13.67B | $5.19B |
| Revenue (TTM) | $1.15B | $1.24B | $2.87B | $813M |
| Net Income (TTM) | $-201M | $632M | $222M | $156M |
| Gross Margin | -9.7% | 85.5% | 21.2% | 63.5% |
| Operating Margin | 19.5% | 64.3% | 18.3% | 29.0% |
| Forward P/E | — | 23.4x | 100.9x | 29.8x |
| Total Debt | $4.15B | $4.26B | $10.44B | $2.55B |
| Cash & Equiv. | $26M | $27M | $538M | $72M |
HR vs OHI vs DOC vs SBRA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Healthcare Realty T… (HR) | 100 | 65.1 | -34.9% |
| Omega Healthcare In… (OHI) | 100 | 148.1 | +48.1% |
| Healthpeak Properti… (DOC) | 100 | 79.8 | -20.2% |
| Sabra Health Care R… (SBRA) | 100 | 152.9 | +52.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HR vs OHI vs DOC vs SBRA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HR is the #2 pick in this set and the best alternative if sleep-well-at-night and defensive is your priority.
- Lower volatility, beta 0.13, Low D/E 88.7%, current ratio 1.75x
- Beta 0.13, yield 5.5%, current ratio 1.75x
- Beta 0.13 vs DOC's 0.52, lower leverage
- +38.2% vs SBRA's +20.5%
OHI carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 14.0%, EPS growth 25.2%, 3Y rev CAGR 10.9%
- 110.0% 10Y total return vs SBRA's 50.9%
- 14.0% FFO/revenue growth vs HR's -6.9%
- Lower P/E (23.4x vs 29.8x)
DOC is the clearest fit if your priority is income & stability.
- Dividend streak 1 yrs, beta 0.52, yield 6.2%
- 6.2% yield, 1-year raise streak, vs HR's 5.5%
SBRA lags the leaders in this set but could rank higher in a more targeted comparison.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 14.0% FFO/revenue growth vs HR's -6.9% | |
| Value | Lower P/E (23.4x vs 29.8x) | |
| Quality / Margins | 51.0% margin vs HR's -17.5% | |
| Stability / Safety | Beta 0.13 vs DOC's 0.52, lower leverage | |
| Dividends | 6.2% yield, 1-year raise streak, vs HR's 5.5% | |
| Momentum (1Y) | +38.2% vs SBRA's +20.5% | |
| Efficiency (ROA) | 6.1% ROA vs HR's -2.1%, ROIC 6.0% vs 0.7% |
HR vs OHI vs DOC vs SBRA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
HR vs OHI vs DOC vs SBRA — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
OHI leads in 2 of 6 categories
DOC leads 2 • HR leads 0 • SBRA leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
OHI leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
DOC is the larger business by revenue, generating $2.9B annually — 3.5x SBRA's $813M. OHI is the more profitable business, keeping 51.0% of every revenue dollar as net income compared to HR's -17.5%. On growth, SBRA holds the edge at +20.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $1.1B | $1.2B | $2.9B | $813M |
| EBITDAEarnings before interest/tax | $767M | $1.1B | $1.6B | $432M |
| Net IncomeAfter-tax profit | -$201M | $632M | $222M | $156M |
| Free Cash FlowCash after capex | $201M | $912M | $1.2B | $367M |
| Gross MarginGross profit ÷ Revenue | -9.7% | +85.5% | +21.2% | +63.5% |
| Operating MarginEBIT ÷ Revenue | +19.5% | +64.3% | +18.3% | +29.0% |
| Net MarginNet income ÷ Revenue | -17.5% | +51.0% | +7.7% | +19.2% |
| FCF MarginFCF ÷ Revenue | +17.5% | +73.6% | +40.2% | +45.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | -10.5% | +16.7% | +7.1% | +20.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +99.8% | +42.4% | +3.6% | -5.9% |
Valuation Metrics
DOC leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 23.8x trailing earnings, OHI trades at a 88% valuation discount to DOC's 196.6x P/E. On an enterprise value basis, DOC's 14.7x EV/EBITDA is more attractive than SBRA's 17.0x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $7.0B | $13.7B | $13.7B | $5.2B |
| Enterprise ValueMkt cap + debt − cash | $11.1B | $18.0B | $23.6B | $7.7B |
| Trailing P/EPrice ÷ TTM EPS | -28.16x | 23.78x | 196.60x | 32.16x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 23.40x | 100.92x | 29.83x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.02x | — | — |
| EV / EBITDAEnterprise value multiple | 16.84x | 16.72x | 14.70x | 17.01x |
| Price / SalesMarket cap ÷ Revenue | 5.91x | 11.47x | 4.84x | 6.70x |
| Price / BookPrice ÷ Book value/share | 1.50x | 2.63x | 1.65x | 1.78x |
| Price / FCFMarket cap ÷ FCF | 54.95x | 15.64x | 11.92x | 14.89x |
Profitability & Efficiency
OHI leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
OHI delivers a 11.9% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-4 for HR. OHI carries lower financial leverage with a 0.78x debt-to-equity ratio, signaling a more conservative balance sheet compared to DOC's 1.26x. On the Piotroski fundamental quality scale (0–9), HR scores 7/9 vs DOC's 4/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -4.3% | +11.9% | +2.6% | +5.6% |
| ROA (TTM)Return on assets | -2.1% | +6.1% | +1.1% | +2.8% |
| ROICReturn on invested capital | +0.7% | +6.0% | +2.3% | +3.8% |
| ROCEReturn on capital employed | +1.0% | +7.9% | +2.8% | +5.2% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 6 | 4 | 5 |
| Debt / EquityFinancial leverage | 0.89x | 0.78x | 1.26x | 0.90x |
| Net DebtTotal debt minus cash | $4.1B | $4.2B | $9.9B | $2.5B |
| Cash & Equiv.Liquid assets | $26M | $27M | $538M | $72M |
| Total DebtShort + long-term debt | $4.1B | $4.3B | $10.4B | $2.6B |
| Interest CoverageEBIT ÷ Interest expense | -0.21x | 3.83x | 1.78x | 2.40x |
Total Returns (Dividends Reinvested)
Evenly matched — OHI and SBRA each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in OHI five years ago would be worth $16,310 today (with dividends reinvested), compared to $8,448 for DOC. Over the past 12 months, HR leads with a +38.2% total return vs SBRA's +20.5%. The 3-year compound annual growth rate (CAGR) favors SBRA at 28.7% vs DOC's 3.9% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +19.4% | +6.6% | +23.9% | +9.0% |
| 1-Year ReturnPast 12 months | +38.2% | +36.9% | +21.0% | +20.5% |
| 3-Year ReturnCumulative with dividends | +17.5% | +86.2% | +12.1% | +113.0% |
| 5-Year ReturnCumulative with dividends | +1.1% | +63.1% | -15.5% | +49.9% |
| 10-Year ReturnCumulative with dividends | +39.6% | +110.0% | +11.2% | +50.9% |
| CAGR (3Y)Annualised 3-year return | +5.5% | +23.0% | +3.9% | +28.7% |
Risk & Volatility
Evenly matched — OHI and DOC each lead in 1 of 2 comparable metrics.
Risk & Volatility
OHI is the less volatile stock with a -0.13 beta — it tends to amplify market swings less than DOC's 0.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DOC currently trades 99.9% from its 52-week high vs OHI's 93.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.13x | -0.13x | 0.52x | -0.06x |
| 52-Week HighHighest price in past year | $20.46 | $49.14 | $19.68 | $21.07 |
| 52-Week LowLowest price in past year | $14.09 | $35.09 | $15.70 | $17.08 |
| % of 52W HighCurrent price vs 52-week peak | +97.7% | +93.9% | +99.9% | +97.7% |
| RSI (14)Momentum oscillator 0–100 | 77.5 | 48.6 | 76.9 | 54.5 |
| Avg Volume (50D)Average daily shares traded | 3.5M | 1.9M | 8.2M | 2.1M |
Analyst Outlook
DOC leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: HR as "Hold", OHI as "Hold", DOC as "Buy", SBRA as "Hold". Consensus price targets imply 6.5% upside for OHI (target: $49) vs -9.2% for DOC (target: $18). For income investors, DOC offers the higher dividend yield at 6.20% vs OHI's 5.44%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | $19.33 | $49.14 | $17.86 | $21.20 |
| # AnalystsCovering analysts | 29 | 28 | 40 | 29 |
| Dividend YieldAnnual dividend ÷ price | +5.5% | +5.4% | +6.2% | +5.8% |
| Dividend StreakConsecutive years of raises | 0 | 0 | 1 | 0 |
| Dividend / ShareAnnual DPS | $1.11 | $2.51 | $1.22 | $1.18 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | 0.0% | +0.7% | 0.0% |
OHI leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). DOC leads in 2 (Valuation Metrics, Analyst Outlook). 2 tied.
HR vs OHI vs DOC vs SBRA: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is HR or OHI or DOC or SBRA a better buy right now?
For growth investors, Omega Healthcare Investors, Inc.
(OHI) is the stronger pick with 14. 0% revenue growth year-over-year, versus -6. 9% for Healthcare Realty Trust Incorporated (HR). Omega Healthcare Investors, Inc. (OHI) offers the better valuation at 23. 8x trailing P/E (23. 4x forward), making it the more compelling value choice. Analysts rate Healthpeak Properties, Inc. (DOC) a "Buy" — based on 40 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — HR or OHI or DOC or SBRA?
On trailing P/E, Omega Healthcare Investors, Inc.
(OHI) is the cheapest at 23. 8x versus Healthpeak Properties, Inc. at 196. 6x. On forward P/E, Omega Healthcare Investors, Inc. is actually cheaper at 23. 4x.
03Which is the better long-term investment — HR or OHI or DOC or SBRA?
Over the past 5 years, Omega Healthcare Investors, Inc.
(OHI) delivered a total return of +63. 1%, compared to -15. 5% for Healthpeak Properties, Inc. (DOC). Over 10 years, the gap is even starker: OHI returned +110. 0% versus DOC's +11. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — HR or OHI or DOC or SBRA?
By beta (market sensitivity over 5 years), Omega Healthcare Investors, Inc.
(OHI) is the lower-risk stock at -0. 13β versus Healthpeak Properties, Inc. 's 0. 52β — meaning DOC is approximately -505% more volatile than OHI relative to the S&P 500. On balance sheet safety, Omega Healthcare Investors, Inc. (OHI) carries a lower debt/equity ratio of 78% versus 126% for Healthpeak Properties, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — HR or OHI or DOC or SBRA?
By revenue growth (latest reported year), Omega Healthcare Investors, Inc.
(OHI) is pulling ahead at 14. 0% versus -6. 9% for Healthcare Realty Trust Incorporated (HR). On earnings-per-share growth, the picture is similar: Healthcare Realty Trust Incorporated grew EPS 60. 8% year-over-year, compared to -72. 2% for Healthpeak Properties, Inc.. Over a 3-year CAGR, DOC leads at 11. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — HR or OHI or DOC or SBRA?
Omega Healthcare Investors, Inc.
(OHI) is the more profitable company, earning 49. 3% net margin versus -20. 8% for Healthcare Realty Trust Incorporated — meaning it keeps 49. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OHI leads at 62. 6% versus 8. 0% for HR. At the gross margin level — before operating expenses — SBRA leads at 65. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is HR or OHI or DOC or SBRA more undervalued right now?
On forward earnings alone, Omega Healthcare Investors, Inc.
(OHI) trades at 23. 4x forward P/E versus 100. 9x for Healthpeak Properties, Inc. — 77. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for OHI: 6. 5% to $49. 14.
08Which pays a better dividend — HR or OHI or DOC or SBRA?
All stocks in this comparison pay dividends.
Healthpeak Properties, Inc. (DOC) offers the highest yield at 6. 2%, versus 5. 4% for Omega Healthcare Investors, Inc. (OHI).
09Is HR or OHI or DOC or SBRA better for a retirement portfolio?
For long-horizon retirement investors, Omega Healthcare Investors, Inc.
(OHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 13), 5. 4% yield, +110. 0% 10Y return). Both have compounded well over 10 years (OHI: +110. 0%, DOC: +11. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between HR and OHI and DOC and SBRA?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.